Published in J Clin Invest on March 01, 1984
A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest (1987) 1.46
Autoantibodies to the heat-shock protein hsp90 in systemic lupus erythematosus. J Clin Invest (1988) 1.45
Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med (2013) 1.34
Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures. J Clin Invest (1984) 1.23
Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Opin Rheumatol (2009) 1.06
DNA receptor dysfunction in systemic lupus erythematosus and kindred disorders. Induction by anti-DNA antibodies, antihistone antibodies, and antireceptor antibodies. J Exp Med (1987) 0.99
Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus. J Clin Invest (1984) 0.92
Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus. Clin Exp Immunol (1990) 0.86
Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies. J Clin Invest (1990) 0.84
Detection of lymphocytotoxic antibodies in relatives of patients with type I diabetes. Br Med J (Clin Res Ed) (1986) 0.82
Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review. Int Med Case Rep J (2014) 0.81
Autoimmunity to a 28-30 kD cell membrane DNA binding protein: occurrence in selected sera from patients with SLE and mixed connective tissue disease (MCTD). Clin Exp Immunol (1991) 0.79
Growth of human B cell colonies from peripheral blood of patients with systemic lupus erythematosus. Ann Rheum Dis (1986) 0.78
Lymphocytotoxic antibodies in systemic lupus erythematosus: studies of their temperature dependence, binding characteristics, and specificity in vitro. Ann Rheum Dis (1988) 0.78
Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity. Clin Exp Immunol (1990) 0.78
Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia. Ann Rheum Dis (1992) 0.77
Lymphocyte subpopulations. Postgrad Med J (1987) 0.75
Serum lymphocytotoxic activity in leprosy. Clin Exp Immunol (1989) 0.75
Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 10.28
Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med (1967) 10.22
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol (1979) 6.08
A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol (1980) 6.05
Characterization of a human B lymphocyte-specific antigen. J Immunol (1980) 5.76
Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol (1979) 5.63
Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J Exp Med (1978) 5.48
Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest (1977) 5.09
Antigens on human monocytes identified by monoclonal antibodies. J Immunol (1981) 4.67
Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39
Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol (1976) 3.08
Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol (1978) 3.07
Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 2.94
Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. J Immunol (1980) 2.93
Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 2.65
Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum (1973) 2.40
Selective loss of suppressor cell function in New Zealand mice induced by NTA. J Immunol (1977) 2.38
Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum (1979) 2.28
Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest (1973) 2.19
Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16
Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med (1973) 2.11
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved. J Immunol (1980) 1.98
Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. J Clin Invest (1978) 1.93
Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum (1972) 1.88
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest (1979) 1.87
The cellular and genetic basis of murine lupus. Immunol Rev (1981) 1.75
Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum (1975) 1.73
Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. J Clin Invest (1980) 1.68
Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1978) 1.54
Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. J Clin Invest (1979) 1.49
B cell and T cell lymphopenia in systemic lupus erythematosus. Cell Immunol (1974) 1.49
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci U S A (1981) 1.47
Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features. Am J Med (1982) 1.46
Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med (1973) 1.45
Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. J Clin Invest (1976) 1.41
Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. Clin Immunol Immunopathol (1980) 1.41
Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest (1981) 1.37
Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis. J Clin Invest (1981) 1.37
Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies. J Immunol (1983) 1.33
The human autologous mixed lymphocyte reaction. III. Immune circuits. J Immunol (1982) 1.27
Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest (1982) 1.19
Communicative interactions between subpopulations of human T lymphocytes required for generation of suppressor effector function in a primary antibody response. J Immunol (1982) 1.18
Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient. Clin Exp Immunol (1976) 1.17
Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol (1974) 1.07
Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function. Scand J Immunol (1979) 1.04
The role of the macrophage in in vitro primary anti-DNP antibody production in man. J Immunol (1981) 1.00
Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. J Clin Invest (1981) 1.00
Immune responses to hapten-modified self and their regulation in normal individuals and patients with SLE. J Immunol (1981) 0.92
Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products. J Immunol (1983) 0.91
Genetic, environmental, and cellular factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum (1982) 0.89
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
The differentiation and function of human T lymphocytes. Cell (1980) 11.88
Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A (1980) 11.23
Monoclonal antibodies defining distinctive human T cell surface antigens. Science (1979) 10.50
Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 10.28
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. J Exp Med (1983) 9.23
An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell (1984) 7.56
A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol (1980) 6.96
The isolation and characterization of the human suppressor inducer T cell subset. J Immunol (1985) 6.69
Specific purification of lymphocyte populations on a digestible immunoabsorbent. J Immunol (1973) 6.64
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol (1979) 6.08
A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol (1980) 6.05
Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A (1982) 5.85
Characterization of a human B lymphocyte-specific antigen. J Immunol (1980) 5.76
The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc Natl Acad Sci U S A (1988) 5.75
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol (1979) 5.63
Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol (1974) 5.50
The isolation and characterization of the human helper inducer T cell subset. J Immunol (1985) 5.21
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med (1979) 5.19
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15
Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor. Nature (1983) 4.96
Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell (1982) 4.86
Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med (1980) 4.80
Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A (1984) 4.78
Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (1990) 4.70
Antigens on human monocytes identified by monoclonal antibodies. J Immunol (1981) 4.67
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med (1978) 4.51
Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J Immunol (1978) 4.33
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med (1989) 4.16
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature (1988) 4.15
Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med (1983) 4.10
Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci U S A (1976) 4.05
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med (1986) 4.01
The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol (1974) 3.98
A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature (1980) 3.90
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci U S A (1991) 3.84
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Distribution of T cell subsets in human lymph nodes. J Exp Med (1981) 3.64
Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science (1995) 3.62
The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol (1980) 3.49
Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med (1980) 3.41
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
A monoclonal antibody blocking human T cell function. Eur J Immunol (1980) 3.33
Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell (1988) 3.25
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med (1987) 3.14
Aberrations of suppressor T cells in human graft-versus-host disease. N Engl J Med (1979) 3.10
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol (1983) 3.09
The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors. Cell (1983) 3.07
Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol (1978) 3.07
Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol (1991) 3.04
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med (1980) 3.03
X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J Exp Med (1975) 3.03
The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain. J Immunol (1973) 3.00
Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 2.94
Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science (1993) 2.93
Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures. Proc Natl Acad Sci U S A (1983) 2.93
Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma (1982) 2.92
Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science (1983) 2.91
Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol (1980) 2.89
Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol (1981) 2.86
The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci U S A (1989) 2.80
Decline in suppressor T cell function with age in female NZB mice. J Immunol (1974) 2.79
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med (2001) 2.77
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 2.74
A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J Exp Med (1988) 2.74
Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med (1987) 2.71
Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med (1989) 2.69
Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science (1990) 2.69